Nirmatrelvir/ritonavir treatment and the risk of post-COVID condition over 180 days in Malaysia

Abstract Background The effect of nirmatrelvir/ritonavir on preventing post-COVID condition (PCC) in the BA4, BA5, and XBB Omicron predominant periods is not well understood. The purpose of this study was to assess how nirmatrelvir/ritonavir treatment affected both PCC and health-related quality of...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ee Vien Low, Mohan Dass Pathmanathan, Yi Yang Ten, Suresh Kumar Chidambaram, Wee Ric Kim, Wei Jia Lee, Zhi Wei Teh, Maheshwara Rao Appannan, Mastura Ismail, Azah Abdul Samad, Kalaiarasu M. Peariasamy
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2024-08-01
coleção:	BMC Infectious Diseases
Assuntos:	Nirmatrelvir/ritonavir post-COVID condition Long COVID Malaysia
Acesso em linha:	https://doi.org/10.1186/s12879-024-09679-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!